Terns Pharmaceuticals has restructured a key licensing deal with China's Hansoh, gaining exclusive worldwide rights for its TERN-701 oncology drug outside Greater China. The strategic move, coupled with a recent analyst price target surge, signals the company's aggressive push into international markets.
In a landmark deal reshaping the U.S. energy landscape, NRG Energy has completed its acquisition of LS Power's 13GW natural gas fleet and virtual power plant platform, significantly boosting its capacity and demand-response capabilities in key markets.
Facing declining core automotive revenue, Tesla announces a radical strategic shift, halting production of flagship luxury models to fund a massive push into robotics and autonomous vehicles. Investors are left weighing ambitious promises against a backdrop of financial strain.
Amidst a complex global economic backdrop, Asia's equity markets are hiding gems trading significantly below their estimated intrinsic value. We spotlight three companies—from gaming to aviation and medtech—that our cash flow analysis suggests are deeply discounted, offering potential for investors with an eye on long-term fundamentals.
The Portuguese government has launched a massive financial aid package, combining loans and direct support, to accelerate recovery from the deadly Storm Kristin which left a trail of destruction across the country last week.
The brutal 2022 murder of Katlyn Lyon Montgomery, a 28-year-old mother, sent shockwaves through her Virginia community. What initially seemed a mystery was unraveled by a relentless investigation that pieced together a stalking ex-boyfriend's digital footprint, leading to a first-degree murder conviction and a life sentence.
Shares of Perspective Therapeutics (CATX) have rallied sharply following encouraging interim results from its lead cancer therapy trial and a strategic business update. While the data fuels optimism, a deep dive into the numbers reveals a stark disconnect between its current market price and analyst targets, highlighting both opportunity and significant risk.
Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.
Biotech firm Definium Therapeutics appoints seasoned commercial executive Roger Adsett to its board, signaling a strategic shift towards commercialization as key late-stage trial data approaches.
Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...
In a major consolidation move within the quantum computing sector, IonQ has announced a definitive agreement to acquire U.S.-based semiconductor foundry SkyWater Technology for $1.8 billion. The deal aims to create a domestically controlled, vertically integrated platform to speed up the development and production of advanced quantum processors, citing both technological and national security imperatives.
Elon Musk reframes Tesla ownership as a potential income source, proposing an 'Airbnb-for-cars' model where private vehicles join an autonomous ride-hailing fleet, offsetting ownership costs.
In a major strategic shift, uranium-focused Energy Fuels announces a deal to acquire Australian Strategic Materials, aiming to create a vertically integrated rare earths producer outside China. The move comes as the company's stock, already on a meteoric rise, faces new questions about its growth trajectory and valuation.
A mountain rescue team in England's Lake District has publicly appealed for two hikers to settle a hotel bill after a costly winter rescue on Scafell Pike, highlighting the financial and ethical pressures faced by volunteer-led emergency services.
Coeur Mining's acquisition of New Gold has received final court approval in British Columbia, marking a pivotal step toward creating a larger, diversified precious metals producer. The deal is poised to reshape the competitive landscape for mid-tier gold and silver miners in North America.
The U.S. State Department has approved significant new arms packages valued at $6.67 billion for Israel and $9 billion for Saudi Arabia. The announcements come as regional tensions flare and the administration pursues a Gaza ceasefire plan.
Extreme Networks reports Q2 revenue of $317.9M and net income of $7.9M, while launching an AI-integrated partner initiative aimed at streamlining sales and driving higher-margin software revenue.
Shareholders of Blue Foundry Bancorp have voted decisively to approve the company's merger agreement with Fulton Financial Corporation, clearing a critical hurdle in the creation of a stronger regional banking entity.
NextEra Energy's unique dual-business model offers investors the stability of a regulated utility alongside the high-growth potential of its renewable energy arm, positioning it as a key player in powering the AI boom.
Wells Fargo updates its long-term valuation for American Electric Power (AEP), raising its price target to $140, as the utility secures a major fuel cell investment and a 20-year power purchase agreement for a new Wyoming facility.
